ARCHIVES

NCI Charging Use Fee for Compounds In Repository

This article is from The Cancer Letter archive.

Vol. 09 No. 32 | August 12, 1983

Download PDF Visit The Full Archive

Related Articles

It’s Official; Most of NCI NTP contingent Will Move To N.C.

February 22, 1980

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

January 6, 1989

Senate Kills Construction Reprograming Plan; NCI To Seek Limit On Future Grant Applications

March 18, 1977